🔎 Trials Near Me

Akèy › Mikoz fungoyid › Kalifòni

Etid klinik pou Mikoz fungoyid nan Kalifòni

11 etid pou Mikoz fungoyid ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

  • City of Hope Medical Foundation, Duarte
  • University of Southern California, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04234048

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • City of Hope, Duarte
  • University of California, Irvine Medical Center - Hematology/Oncology, Orange
  • Stanford University School of Medicine, Stanford
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

  • City of Hope Medical Center, Duarte
  • Stanford Cancer Institute Palo Alto, Palo Alto
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07003100

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

  • City of Hope Comprehensive Cancer Cente, Duarte
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06854653

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

  • City of Hope Medical Center, Duarte
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04930653

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

  • City of Hope Medical Center, Duarte
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT03011814

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

  • Stanford Cancer Center, Stanford
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT04256018

A Registry for People With T-cell Lymphoma

  • City of Hope Cancer Center (Data collection only), Duarte
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only), San Diego
  • University of California San Francisco (Data collection only), San Francisco
  • ak 1 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 20, 2026 · NCT05978141

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

  • Stanford University Medical Center, Stanford
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 3, 2026 · NCT03587844

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

  • City of Hope, Duarte
  • Stanford University, School of Medicine, Palo Alto
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 22, 2025 · NCT02848274

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.